Cytokine response to diabetic ketoacidosis and its treatment

William H. Hoffman, C. Lynne Burek, Jennifer L. Waller, Lyle E. Fisher, Mahmood Khichi, Larry B. Mellick

Research output: Contribution to journalArticlepeer-review

91 Scopus citations


The objectives of this study were to monitor plasma cytokines as markers of cellular activation and as potential markers for the progression of the acute complications of diabetic ketoacidosis (DKA). Blood samples were obtained prior to, during and after treatment of severe DKA (pH < 7.2) in six children and adolescents. Plasma IL-10, IL-1β, TNF-α, IL-6, IL-8 and IL-2 cytokine levels were assayed by ELISA at each of the time points. Prior to treatment, elevations of multiple cytokines were found, the highest being IL-10. Treatment of DKA resulted in a significant decrease of IL-10 at 6-8 h (p = 0.0062), and further increases in the inflammatory cytokines at 6-8 h and/or 24 h vs 120 h (baseline): IL-1β (p = .0048); TNF-α (p = .0188) and IL-8 (p = .0048). This study strengthens the hypothesis that the metabolic crisis of DKA, and its treatment, have differential effects on cellular activation and cytokine release. The time frame for the increase in inflammatory cytokines correlates with the reported progression of subclinical brain edema, interstitial pulmonary edema and the development of clinical brain edema.

Original languageEnglish (US)
Pages (from-to)175-181
Number of pages7
JournalClinical Immunology
Issue number3
StatePublished - Sep 1 2003


  • Cellular activation
  • Cytokines
  • Diabetic ketoacidosis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Cytokine response to diabetic ketoacidosis and its treatment'. Together they form a unique fingerprint.

Cite this